lenalidomide has been researched along with interleukin-8 in 2 studies
| Studies (lenalidomide) | Trials (lenalidomide) | Recent Studies (post-2010) (lenalidomide) | Studies (interleukin-8) | Trials (interleukin-8) | Recent Studies (post-2010) (interleukin-8) |
|---|---|---|---|---|---|
| 3,532 | 725 | 2,850 | 23,523 | 1,167 | 9,990 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Antonarakis, ES; Carducci, M; Drake, CG; Eisenberger, MA; Keizman, D; McNeel, DG; Smith, HA; Thoburn, CJ; Zabransky, DJ; Zahurak, M | 1 |
| Amiot, M; Bonnaud, S; Gomez-Bougie, P; Gratas, C; Le Gouill, S; Maïga, S; Moreau, P; Pellat-Deceunynck, C | 1 |
1 trial(s) available for lenalidomide and interleukin-8
| Article | Year |
|---|---|
Lenalidomide modulates IL-8 and anti-prostate antibody levels in men with biochemically recurrent prostate cancer.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antigens, Surface; Antineoplastic Agents; Biomarkers, Tumor; Disease Progression; Humans; Immunomodulation; Interleukin-8; Lenalidomide; Male; Middle Aged; Neoplasm Recurrence, Local; Prostate-Specific Antigen; Prostatectomy; Prostatic Neoplasms; Radiotherapy, Adjuvant; Retrospective Studies; Thalidomide | 2012 |
1 other study(ies) available for lenalidomide and interleukin-8
| Article | Year |
|---|---|
Paradoxical effect of lenalidomide on cytokine/growth factor profiles in multiple myeloma.
Topics: Angiogenesis Inhibitors; Antineoplastic Agents; Bone Marrow Cells; Cell Line, Tumor; Cell Proliferation; Drug Resistance, Neoplasm; Humans; Immunologic Factors; Insulin-Like Growth Factor I; Interleukin-8; Lenalidomide; Multiple Myeloma; Thalidomide; Tumor Necrosis Factor-alpha | 2013 |